about
ErbB2 signaling at the crossing between heart failure and cancerVitamin D3-upregulated protein-1 (VDUP-1) regulates redox-dependent vascular smooth muscle cell proliferation through interaction with thioredoxinActivation of the neuregulin/ErbB system during physiological ventricular remodeling in pregnancy.Elastin fragmentation in atherosclerotic mice leads to intraplaque neovascularization, plaque rupture, myocardial infarction, stroke, and sudden death.Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction.Molecular mechanisms of cardiotoxicity induced by ErbB receptor inhibitor cancer therapeuticsDiastolic heart failure: a myth.Systolic and diastolic heart failure: different phenotypes of the same disease?Diastolic heart failure: a separate disease or selection bias?Neuregulin-1 attenuates development of nephropathy in a type 1 diabetes mouse model with high cardiovascular riskRole of neuregulin-1/ErbB signaling in cardiovascular physiology and disease: implications for therapy of heart failure.The vulnerability of the heart as a pluricellular paracrine organ: lessons from unexpected triggers of heart failure in targeted ErbB2 anticancer therapy.Role of autophagy in heart failure associated with aging.Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology.Pulmonary hypertension and right heart failure in heart failure with preserved left ventricular ejection fraction: pathophysiology and natural history.Therapeutic potential of neuregulin-1 in cardiovascular disease.Cardiotoxicity associated with cancer therapy: pathophysiology and prevention strategies.Expression and spatial heterogeneity of dipeptidyl peptidases in endothelial cells of conduct vessels and capillaries.How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology.Endocardial endothelium modulates subendocardial pH(i) of rabbit papillary muscles: role of transendothelial HCO(3)(-) transport.Effect of angiotensin II-induced arterial hypertension on the voltage-dependent contractions of mouse arteries.A novel set-up for the ex vivo analysis of mechanical properties of mouse aortic segments stretched at physiological pressure and frequency.Endothelial function in aorta segments of apolipoprotein E-deficient mice before development of atherosclerotic lesions.Effect of the long-term administration of nebivolol on clinical symptoms, exercise capacity and left ventricular function in patients with heart failure and preserved left ventricular ejection fraction: background, aims and design of the ELANDD studIdentification of IEX-1 as a biomechanically controlled nuclear factor-kappaB target gene that inhibits cardiomyocyte hypertrophy.Phenotypical characterization of α-galactosidase A gene mutations identified in a large Fabry disease screening program in stroke in the young.Neuregulin-1 induces a negative inotropic effect in cardiac muscle: role of nitric oxide synthase.Inhibition of heme oxygenase-1 impairs cardiac muscle sensitivity to beta-adrenergic stimulation.Impact of radiofrequency characteristics on acute pulmonary vein reconnection and clinical outcome after PVAC ablation.Effect of a telemonitoring-facilitated collaboration between general practitioner and heart failure clinic on mortality and rehospitalization rates in severe heart failure: the TEMA-HF 1 (TElemonitoring in the MAnagement of Heart Failure) study.Ventricular ErbB2/ErbB4 activation and downstream signaling in pacing-induced heart failure.Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study.Chronic intermittent mental stress promotes atherosclerotic plaque vulnerability, myocardial infarction and sudden death in mice.Evidence that intracoronary-injected CD133+ peripheral blood progenitor cells home to the myocardium in chronic postinfarction heart failure.Role of neuregulin-1/ErbB2 signaling in endothelium-cardiomyocyte cross-talk.Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction.Prevalence, characteristics, and predictors of pulmonary vein narrowing after isolation using the pulmonary vein ablation catheter.Pulmonary vein stenosis after pulmonary vein ablation catheter-guided pulmonary vein isolation.Left ventricular diastolic dysfunction and myocardial stiffness in diabetic mice is attenuated by inhibition of dipeptidyl peptidase 4.Neuregulin-1 improves right ventricular function and attenuates experimental pulmonary arterial hypertension
P50
Q28075244-E29CB4AD-3D0E-444C-B8C5-9F0158ADDECAQ28208305-D4D0754B-7B34-4DB9-AA74-7B652F046B87Q29347286-1827717E-44CB-4DF3-B152-44E46C1ACEE4Q30646015-366C62BB-5F86-43F6-B745-69F1B9FC3789Q34603397-9F3CCF10-5478-4EF1-8652-38BF314B234DQ36396421-435FECEA-AF57-496B-9CC7-5798F29C4414Q36443178-18E7564A-4034-43FA-A79A-7C2669D26B5BQ36555162-6173B18A-1461-4D14-8295-B9FDEDC8F038Q36690649-421CB8FD-9702-4FD5-A70E-8B1AD08142CEQ36775652-758BC44D-CC10-49E4-8286-CEDC4564E4C7Q36914725-40E1BEE8-4A9A-4928-9940-C6AE2A659463Q37670521-FE271AD7-DFAF-485D-A1CB-6E3AE20EFE9AQ37728936-E409DD49-DD73-42A4-B770-5361003CA0BDQ37822215-226834A0-83D7-4F3E-8378-E0E5E93B65F8Q37983384-A32735F9-81EE-4D98-9CA9-A4749786F020Q38079353-598B24B9-BEBC-40D5-9EB6-7AF9BCB6763BQ38102433-6A9BF08E-8921-4D7A-BE33-3246F40C842DQ39613724-5EDACDD1-ED41-4E60-B2B0-A56B19D08453Q40224176-7217D7A6-EA8D-4B90-8C3A-13D87379426EQ42466070-3E4FDC18-AEAD-49AB-8F64-5ADA56B98E2FQ42483189-4BB6CF9E-15AB-4E92-B880-59F08E32D36AQ42494143-1CC857FD-7E1E-453A-B792-674321985094Q42519453-AC6EB5E5-ACAA-44B2-88F5-70AC9FCB74FAQ43205980-5618FBC2-65C8-460A-9FFD-B81016D923DDQ43948827-B367C842-81A5-4699-A2F1-2F03E365DED6Q44296121-EC475F1A-A93F-4846-B913-FC488B2DAF44Q44734583-255A7CD7-492C-44B6-B772-D6673AE9D935Q45210396-EA3CBC02-0677-4A3F-A090-D747825131E7Q45230998-6C05C6A8-F27D-49C2-90F2-FDBF070BCC7EQ45382854-7E791318-7E0D-4884-821D-B4B1651E4E9EQ46245905-95A1D558-8CA0-4C59-BDA4-59F62600E397Q48795012-AEA61539-3B65-4EBB-9D5A-A74F9A40E90BQ50576198-104AEC3D-4D52-41E5-9E44-DA8FB02F4D3DQ50894332-C7082B2D-F916-4031-B716-3EA2BB683FE3Q51202656-42BA8C24-A92A-4DB4-8AD5-16502C8C8A7CQ52859591-21932392-AA5E-42B3-8F81-F03BFF8AA4BAQ53192887-93C4C61E-413A-4405-A5D3-A88A5B8184ABQ53299972-7714DBD4-B217-438F-836E-40E192DDDC52Q54313660-D9F6A980-19DB-443D-A63F-F70FFBC008D3Q57805025-E47EE1A2-3519-4987-AC41-73E2613F069E
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Gilles W De Keulenaer
@ast
Gilles W De Keulenaer
@en
Gilles W De Keulenaer
@es
Gilles W De Keulenaer
@nl
Gilles W De Keulenaer
@sl
type
label
Gilles W De Keulenaer
@ast
Gilles W De Keulenaer
@en
Gilles W De Keulenaer
@es
Gilles W De Keulenaer
@nl
Gilles W De Keulenaer
@sl
prefLabel
Gilles W De Keulenaer
@ast
Gilles W De Keulenaer
@en
Gilles W De Keulenaer
@es
Gilles W De Keulenaer
@nl
Gilles W De Keulenaer
@sl
P1053
D-9321-2017
P106
P21
P31
P3829
P496
0000-0002-4238-4183